Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...

Calhoun Community College hosted an open house for a new respiratory therapy program on Wednesday.

In the world of Mexican music, Vicente Fernandez became a cultural icon. His children followed in his musical footsteps, ...

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...